Avenra is developing first-in-class phytoceutical drugs to target prevention of cognitive decline and dementia -- delivering therapy before decline starts.

Complex diseases like cognitive decline and dementia are treated after they start. 

What if we could prevent it?

Avenra is at the forefront of answering this question.  We provide FDA-approved solutions that aren't supplements and aren't traditional drugs. This isn't a supplement.   It's not "food as medicine".  It's a new class of FDA-approved drug that's revolutionizing healthcare.